Operating Lease, Liability in USD of Arbutus Biopharma Corp from Q1 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Arbutus Biopharma Corp quarterly Operating Lease, Liability history and change rate from Q1 2019 to Q4 2024.
  • Arbutus Biopharma Corp Operating Lease, Liability for the quarter ending 31 Dec 2024 was $1.29M, a 27.1% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

Arbutus Biopharma Corp Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $1.29M -$479K -27.1% 31 Dec 2024 10-K 27 Mar 2025
Q4 2023 $1.77M -$419K -19.2% 31 Dec 2023 10-K 05 Mar 2024
Q4 2022 $2.19M -$427K -16.3% 31 Dec 2022 10-K 02 Mar 2023
Q4 2021 $2.61M -$369K -12.4% 31 Dec 2021 10-K 03 Mar 2022
Q4 2020 $2.98M -$376K -11.2% 31 Dec 2020 10-K 04 Mar 2021
Q4 2019 $3.36M 31 Dec 2019 10-K 05 Mar 2020
Q3 2019 $3.47M 30 Sep 2019 10-Q 06 Nov 2019
Q2 2019 $3.64M 30 Jun 2019 10-Q 05 Aug 2019
Q1 2019 $3.87M 31 Mar 2019 10-Q 06 May 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.